1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.2174/138920112798868791" target="_blank" rel="noreferrer noopener">http://doi.org/10.2174/138920112798868791</a>
Pages
218–228
Issue
1
Volume
13
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Curcumin and liver cancer: a review.
Publisher
An entity responsible for making the resource available
Current pharmaceutical biotechnology
Date
A point or period of time associated with an event in the lifecycle of the resource
2012
2012-01
Subject
The topic of the resource
Humans; Animals; Anticarcinogenic Agents/*therapeutic use; Antioxidants/therapeutic use; Anti-Inflammatory Agents/therapeutic use; Curcumin/*therapeutic use; Liver Neoplasms/*drug therapy/prevention & control; Carcinoma; Antineoplastic Agents; Hepatocellular/*drug therapy/prevention & control; Phytogenic/*therapeutic use
Creator
An entity primarily responsible for making the resource
Darvesh Altaf S; Aggarwal Bharat B; Bishayee Anupam
Description
An account of the resource
Primary liver cancer, also known as hepatocellular carcinoma (HCC), is one of the most lethal cancers having worldwide prevalence. Although most HCC cases are reported in the developing countries of Asia and Africa, there has been an alarming increase in HCC cases in Western Europe as well as United States. Chronic liver diseases, viral hepatitis, alcoholism as well as dietary carcinogens, such as aflatoxins and nitrosoamines, contribute to HCC. Liver transplantation as well as surgical resection at best offer limited treatment options. Thus, there exists a critical need to investigate and evaluate possible alternative chemopreventive and therapeutic strategies which may be effective in the control of liver cancer. HCC, most often, develops and progresses in a milieu of oxidative stress and inflammation. Phytochemicals, such as dietary polyphenols endowed with potent antioxidant as well as anti-inflammatory properties, provide a suitable alternative in affording alleviation of HCC. Curcumin, the principal polyphenolic curcuminoid, obtained from the turmeric rhizome Curcuma longa has long been used to cure several chronic ailments, such as neoplastic and neurodegenerative diseases. Studies suggest that curcumin may have antitumor, antioxidant, and anti-inflammatory properties. This article reviews the effects of curcumin in preclinical in vitro and in vivo models of HCC with particular emphasis to its antioxidant, apoptotic and anti-inflammatory effects as well as involvement in various molecular signaling mechanisms. This review also discusses potential challenges involved in the use of curcumin in HCC, such as bioavailability, pharmacokinetics, drug delivery as well as paucity of clinical studies.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.2174/138920112798868791" target="_blank" rel="noreferrer noopener">10.2174/138920112798868791</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2012
Aggarwal Bharat B
Animals
Anti-Inflammatory Agents/therapeutic use
Anticarcinogenic Agents/*therapeutic use
Antineoplastic Agents
Antioxidants/therapeutic use
Bishayee Anupam
Carcinoma
Curcumin/*therapeutic use
Current pharmaceutical biotechnology
Darvesh Altaf S
Department of Pharmaceutical Sciences
Hepatocellular/*drug therapy/prevention & control
Humans
Liver Neoplasms/*drug therapy/prevention & control
NEOMED College of Pharmacy
Phytogenic/*therapeutic use